Navigation Links
NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
Date:8/5/2009

al Flu vaccine."

"The accomplishments announced today further validate our strategy to create a rapid, in-border influenza vaccine solution for governments around the world by addressing gaps in currently available vaccine technologies," added Dr. Rahul Singhvi, President and CEO of Novavax, Inc.

Novavax, Inc has successfully completed a Phase I/IIa clinical study with a candidate H5N1 influenza VLP vaccine and is currently in Phase II trials with a VLP based seasonal flu vaccine candidate. The Company plans to initiate a Phase II study with its Seasonal Flu vaccine candidate in the elderly population during Q4, 2009.

About Novavax

Novavax, Inc. is a clinical-stage biotechnology company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like particle (VLP) technology. The company produces these VLP-based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at www.novavax.com and in the company's various filings with the Securities and Exchange Commission.

Forward Looking Statements

Statements herein relating to future financial or business performance, conditions or strategies and other financial and business matters, including expectations regarding revenues, operating expenses, cash burn, and clinical developments and anticipated milestones are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the Company's ability to progress
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
2. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
3. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
4. Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate
5. Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate
6. NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting
7. NOVAVAX CEO to Present at 2008 UBS Global Life Sciences Conference
8. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
9. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
10. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
11. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... HILL, N.C. , April 17, 2015 /PRNewswire/ ... the creation of many new forms of provider ... Accountable Care Organizations (ACOs). The rapid evolution of ... to adapt their access, pricing and service delivery ... networks. To help the pharma sector ...
(Date:4/17/2015)... , April 17, 2015 Inivata, ... company announced today that their presence at the 2015 American ... a presentation by co-founder Nitzan Rosenfeld and a ... attending April 18 th - 22 nd . ... plasma using ctDNA , forms part of a ...
(Date:4/17/2015)... , Apr. 17, 2015 Research and Markets ... the "ADME-Toxicology Testing - Global Strategic Business Report" ... analyzes the worldwide markets for ADME-Toxicology Testing in US$ ... In-Vitro), and ADME Testing. The report provides ... , Japan , ...
Breaking Medicine Technology:Pharmaceutical Industry Struggling to Better Serve Provider Networks Such as Accountable Care Organizations (ACOs) 2Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2
... The American Association of,Health Freedom and the ... at the Baromedical Research,Institute and Louisiana State ... the successful treatment of chronic traumatic brain ... (2007 Oct 12;1174:120-9),are purportedly the first-ever demonstration ...
... Statement and National HIV/AIDS Elimination Act, NEW YORK, ... role of,advancing prophetic social justice ministry, Black clergy are ... for theologically,sound HIV/AIDS public policy. Working with the National ... live up to the biblical,mandate that calls us to ...
Cached Medicine Technology:Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury 2Statement From The National Conclave on HIV/AIDS Policy for Black Clergy 2Statement From The National Conclave on HIV/AIDS Policy for Black Clergy 3
(Date:4/18/2015)... More than 2000 styles of newly designed prom ... online store carrying celebrity inspired special occasion dresses. With ... perfect dresses for their prom. For those who are ... TheCelebrityDresses.com would be an ideal choice. , "We ... inspired by the most loved styles seen at this ...
(Date:4/18/2015)... Aureus Medical Group (web: aureusmedical.com), ... therapy jobs, has announced that it will participate ... Therapy Association Annual Conference to be held May ... SC. , The SCAPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
(Date:4/18/2015)... PHOENIX, ARIZONA – In March, Mark Ona, ... secure destruction professionals across the United States, earned the ... now display “CSDS” as a professional title with his ... Association of Information Destruction 2015 Annual Conference began - ... the 20 people who took the exam, Ona was ...
(Date:4/17/2015)... Bradley, Illinois (PRWEB) April 18, 2015 ... community, will begin its Supportive Living Week Celebration on ... focus on having a healthy mind, body and soul. ... Marshall in McLeansboro, Illinois, serves older adults of all ... to maintain their independence. , Supportive Living Week is ...
(Date:4/17/2015)... 2015 Rosetta Radiology is proud to ... their list of diagnostic imaging services. This solidifies them ... the Upper East Side of Manhattan. , The new ... The addition of PET-CT, combined with Rosetta’s state of ... to work with patients through several stages of the ...
Breaking Medicine News(10 mins):Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3
... , , EL SEGUNDO, Calif., ... ), the only national organization creating hope in a comprehensive ... cure is mourning the loss of legendary actor Patrick Swayze. His ... subsequent battle put a spotlight on pancreatic cancer, the fourth leading ...
... , , ... , CHARLESTON, S.C., Sept. 14 According to ... without a prescription, despite efforts to control antibiotic-resistant bacteria as a ... Using a keyword search of "purchase antibiotics without a prescription" ...
... Sept. 14 HealthSouth Corporation (NYSE: HLS ) announced ... dividend of $16.25 per share on its 6.5% Series A Convertible ... record on Oct. 1, 2009. , , ... of inpatient rehabilitative healthcare services. Operating in 26 states across the ...
... officials say , MONDAY, Sept. 14 (HealthDay News) -- With ... officials on Monday urged small businesses to prepare now to ... , "We need to make sure that operations and businesses ... Janet Napolitano, U.S. Secretary of Homeland Security, said during an ...
... up chances of other cancers, clots , MONDAY, Sept. ... high risk for developing breast cancer do reduce their ... a new analysis suggests. , That was the conclusion ... randomized clinical trials and a head-to-head assessment of the ...
... , HOPKINTON, Mass., Sept. ... the world leader in information infrastructure solutions, today announced ... with more than 25,000 healthcare provider customers, has consolidated ... RSA and VMware solutions. As a result, eClinicalWorks ...
Cached Medicine News:Health News:The Pancreatic Cancer Action Network Is Saddened by the Death of Actor Patrick Swayze 2Health News:MUSC Researchers Concerned About Online Drug Availability 2Health News:Small Businesses Urged to Prepare for Swine Flu 2Health News:Medications That Lower Breast Cancer Risk Carry Other Dangers 2Health News:Medications That Lower Breast Cancer Risk Carry Other Dangers 3Health News:eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 2Health News:eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 3
... System has been developed specifically to fight ... buttocks and hips. It does this by ... excess fluids in your body, which then ... CELLUSSAGE daily, for about 15 minutes each ...
... non-invasive way of shaping your body, ... improving overall skin fitness. ,In its ... rehabilitate scars, burns and damaged muscular ... discovered - the reduction of cellulite ...
... people, you must understand the patients you ... an increasingly aging population, your patients may ... With an incredible 18-inch low height, the ... easy for your practice to accommodate the ...
... is the only treatment of ... topical dermaceutical while exfoliating the ... skin types and addresses a ... including hyperpigmentation, acne, photodamage, dehydration ...
Medicine Products: